Answers are grounded in this paper and cite their sources.
The results presented here demonstrate that the Quantum® can be used to expand large numbers of MSCs from bone marrow and umbilical cord tissues for next-generation large-scale manufacturing, without impacting on many of the properties that are characteristic of MSCs or potentially therapeutic. Using the Quantum®, we can obtain multiple MSC doses from a single manufacturing run to treat many patients. Together, our findings support the development of cheaper cell-based treatments.
No takes yet. Share an insight, caveat, or question.
Mennan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: